Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Genital Neoplasms, Female × fosaprepitant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 2 Uterine Cervical Neoplasms 1 Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy 1 Neoplasms 1 Nausea 1 Nasopharyngeal Neoplasms 1 Gynecologic Cancer 1 Genital Neoplasms, Female 1

Interventions

Gemcitabine 2 liposomal doxorubicin 1 fosaprepitant 1 argatroban 1 Palonosetron 1 Paclitaxel 1 Heparin, Low-Molecular-Weight 1 Drug Therapy 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01074697 2015-04-24

GAND-emesis

Odense University Hospital

Phase 3 Completed

Genital Neoplasms, Female, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡